What's new

Pakistan Pharma Industry in fear of closure after Indian Offer.

So you are suggesting that it doesn't matters if Pakistan companies shutdown, huge jobless people become criminals & economy gets collapse. India can invest in Pakistan there are alot of sectors which can benifit India as well as Pakistan & for that the top most sector is Power sector. Remember when people will have jobs they can buy anything otherwise if companies keep on shutting down, Pakistan will become Afghanistan because Pakistan don't have oil or other source to survive.
you seem to be totally misinterpreted see pharma industry is totally different from any other you can survive without cars but not without medicines let me give you a example ....... 1o years from now no body knew about cetuximab (a drug used in cancers ) except from books they then started importing it from US this makes a market for these drugs then the local manufacture started with good results some local companies stated R&D now they have made Nimotuzumab a more potent and all made in india product now this is being imported to U.S.AND OTHERS EVEN CHINA
Cipla to invest $65 million in MabPharm, China’s BioMab
 
.
we dont like to keep other's property. you gave us a lot of fake rupees. The least we can do ...

Pharma industry fears closure after MFN to India


Health experts and pharmaceutical manufacturers on Sunday said that around 20 to 25 per cent drugs manufactured in India were spurious. "India, being world’s largest manufacturer of generic drugs, has become a busy center for counterfeit and substandard medicines. Stuffed in slick packaging, the fake drugs are passed on to consumers and sold in developing nations around the world," Chairman of Pharmaceutical Business Association (Regd), Aslam Naqqash said.
.
 
.
India had similar mindset prior to 1991 and we nearly went bankrupt. you can not survive with a protectionist mindset in this rapidly globalizing world. Competing with foreign companies helped indian companies to improve their own standards and now we have some world class facilities. the same will happen to pakistan
But during the protectionist period India also had local industrial giants that engaged in joint ventures and used the Indian market size and exports to grow even more after then end of protectionism.

India did not face cheap or cheaper imports from China or Pakistan during that phase of opening up.

Pakistan needs to open its markets, but I believe that Indian companies that are producing products competing with Pakistani produced products, should be required to manufacture those products in Pakistan, with a mandatory local partner.
 
.
Pakistani's here need to realize that "cheap" as described by westerners is different from the South Asian perspective of it. Indian pharmaceutical companies are reported to have 200 or even 300 percent profit margins in some cases. Except from the everyday drugs like aspirin or anti-allergens which go for a pittance, most other drugs are not exactly cheap. These are exactly the kind of drugs that the Indian pharmaceutical companies would export to Pakistan as there is no apparent volumes game involved here.
Unless there are loads of Pakistani pharma manufacturers producing these high end drugs, there should be no major issues here. And even if there are, I doubt the Indian drugs would be cheaper than the Local ones.

Frankly, it would end up helping Pakistan gain access to life saving drugs that may not be as readily available today.
 
.
But during the protectionist period India also had local industrial giants that engaged in joint ventures and used the Indian market size and exports to grow even more after then end of protectionism.

India did not face cheap or cheaper imports from China or Pakistan during that phase of opening up.

Pakistan needs to open its markets, but I believe that Indian companies that are producing products competing with Pakistani produced products, should be required to manufacture those products in Pakistan, with a mandatory local partner.

Yes, I think India did the same initially when it was opening up to the world, However here Pakistan is already a Free Market. Challenge would be How would you do have different standard for US / Chinese companies and different one for Indian.

Lets face it, China has completely whitewashed manufacturing sector (other then precision and strategic industry) of all the countries and that includes Pakistan.
No one can match their productivity.

In case of Pakistan India, Pakistan should see that what benefit its other industries can leverage out of this engagement. Bottom line can be drawn like:

India exports $5 Mil and Pakistan Exports $5M to India
 
.
But during the protectionist period India also had local industrial giants that engaged in joint ventures and used the Indian market size and exports to grow even more after then end of protectionism.

India did not face cheap or cheaper imports from China or Pakistan during that phase of opening up.

Pakistan needs to open its markets, but I believe that Indian companies that are producing products competing with Pakistani produced products, should be required to manufacture those products in Pakistan, with a mandatory local partner.

Wouldnt that take away the benefit of scale which is a key factor in reducing the cost of medicine..
 
.
India's medicine is of poor quality. They don't even manufacture updated drugs. For asthma, for instance. We in BD have a huge open trade in our manufactured medicines entering India. Even patients going to India are told to buy medicines when they get back to BD.
 
.
India's medicine is of poor quality. They don't even manufacture updated drugs. For asthma, for instance. We in BD have a huge open trade in our manufactured medicines entering India. Even patients going to India are told to buy medicines when they get back to BD.

INDUSTRY & SERVICES

PHARMACEUTICALS

Overview of Pharmaceutical Industry

The Indian Pharmaceutical Industry currently tops the chart amongst India 's science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. The Indian Pharmaceutical Industry ranks very high amongst all third world countries, in terms of technology, quality and the vast range of medicines that are manufactured.

The Pharmaceutical industry has grown from mere US$ 0.3 billion turnover in 1980 to about US$ 21.73 billion in 2009-10. The country now ranks 3 rd in terms of volume of production (10 per cent of global share) an 14 th largest by value (1.5 per cent of global share). One reason for lower value share is the lowest cost of drugs in India ranging from 5 per cent to 50 per cent less as compared to developed countries. Indian pharmaceutical industry growth has been fuelled by exports and its products are exported to a large number of countries with a sizeable share in the advanced regulated markets of the US and Western Europe .

Many Indian companies maintain highest standards in Purity, Stability and International Safety, Health and Environmental (SHE) protection in production and supply of bulk drugs even to some innovator companies. This speaks of the high quality standards maintained by a large number of Indian Pharma companies as these bulk actives are used by the buyer companies in manufacture of dosage forms which are again subjected to stringent assessment by various regulatory authorities in the importing countries. More of Indian companies are now seeking regulatory approvals in USA in specialized segments like Anti-infectives, Cardiovasculars, CNS group. Along with Brazil & PR China, India has carved a niche for itself by being a top generic Pharma player.

Increasing number of Indian pharmaceutical companies have been getting international regulatory approvals for their plants from agencies like USFDA (USA), MHRA (UK), TGA (Australia), MCC (South Africa), Health Canada etc. India has the largest number of USFDA-approved plants for generic manufacture. Considering that the pharmaceutical industry involves sophisticated technology and stringent "Good Manufacturing Practice (GMP) requirements, major share of Indian Pharma exports going to highly developed western countries bears testimony to not only the excellent quality of Indian pharmaceuticals but also its price competitiveness. More than 50 per cent share of exports is by way of dosage forms. Indian companies are now seeking more Abbreviated New Drug Approvals (ANDAs) in USA in specialized segments like anti-infective, cardio vascular and central nervous system groups.

Exports

India currently exports drug intermediates, Active Pharmaceutical Ingredients (APIs), Finished Dosage Formulations (FDFs), Bio-Pharmaceuticals, Clinical Services to various parts of the world.

Export of Drugs and pharmaceuticals from 2007-08 to 2009-10 are given below:

Year


Exports
(US$ billion)

Growth
(in percent)

2007-08


6.3


14.4

2008-09


8.6


35.7
2009-10

9.1


5.9

Source: Directorate General of Commercial Intelligence and Statistics (DGCIS) Kolkata

The domestic Pharma Industry

The domestic Pharma Industry has recently achieved some historic milestones through a leadership position and global presence as a world class cost effective generic drugs' manufacturer of AIDS medicines. Many Indian companies are part of an agreement where major AIDS drugs based on Lamivudine, Stavudine, Zidovudine, Nevirapine will be supplied to Mozambique, Rwanda, South Africa and Tanzania which have about 33 per cent of all people living with AIDS in Africa. Yet another US Scheme envisages sourcing Anti Retrovirals from some Indian companies whose products are already US FDA approved.

Many Indian companies maintain highest standards in Purity, Stability and International Safety, Health and Environmental (SHE) protection in production and supply of bulk drugs even to some innovator companies. This speaks of the high quality standards maintained by a large number of Indian Pharma companies as these bulk actives are used by the buyer companies in manufacture of dosage forms which are again subjected to stringent assessment by various regulatory authorities in the importing countries. More of Indian companies are now seeking regulatory approvals in USA in specialized segments like Anti-infectives, Cardiovasculars, CNS group. Along with Brazil & PR China, India has carved a niche for itself by being a top generic Pharma player.

Increasing number of Indian pharmaceutical companies have been getting international regulatory approvals for their plants from agencies like USFDA (USA), MHRA (UK), TGA (Australia), MCC (South Africa), Health Canada etc. India has the largest number of USFDA - approved plants for generic manufacture. Considering that the pharmaceutical industry involves sophisticated technology and stringent "Good Manufacturing Practice (GMP) requirements, major share of Indian Pharma exports going to highly developed western countries bears testimony to not only the excellent quality of Indian pharmaceuticals but also its price competitiveness. More than 50 per cent share of exports is by way of dosage forms. Indian companies are now seeking more Abbreviated New Drug Approvals (ANDAs) in USA in specialized segments like anti-infective, cardio vascular and central nervous system groups.
 
.
Pharmaceuticals
Last Updated: August 2011

The pharmaceutical industry in India is valued at US$ 12 billion with an annual compound annual growth rate (CAGR) of 10-11 per cent. The industry spends around 18 per cent of its revenue on research and development (R&D). In India, the clinical research industry is estimated to be a US$ 2.2 billion with a healthy CAGR of 23 per cent. India is ranked as the third largest emerging market and is growing fastest in conducting number of trials.

Moreover, India is expected to join the league of top 10 global pharmaceuticals markets in terms of sales by 2020 with the total value reaching US$ 50 billion, according to a report by PricewaterhouseCoopers (PwC).

Sector Structure/ Market Size

The Indian pharmaceutical market is poised to grow to US$ 55 billion by 2020 from the 2009 levels of US$ 12.6 billion, as per a McKinsey & Company report titled “ India Pharma 2020: Propelling access and acceptance realising true potential”. The industry further holds potential to reach US$ 70 billion, at a CAGR of 17 per cent.

The pharma industry constitutes around 8 per cent of the world’s pharmaceutical production. Over the last couple of years, Indian pharma companies have been increasingly targeted by multinationals for both collaborative agreements and acquisition, as per an Espicom report titled, “The Pharmaceutical Market: India Opportunities and Challenges”. The report further echoes the sentiments and the trends of the industry in totality.

Exports

India’s exports of drugs, pharmaceutical & fine chemicals stood at US$ 9.26 billion during April 2010–Feb 2011, up 16.15 per cent as compared to US$ 7.97 billion in the same period during the previous year. India’s exports has recorded a growth rate of over 20.07 per cent, during the period of the two financial years in the study and the exports to rest of the world has grown by 9 per cent, according to DGCIS data from Pharmexcil Research.

Growth

The drugs and pharmaceuticals sector attracted foreign direct investments (FDI) worth US$ 4.84 billion between April 2000 and May 2011, according to data published by Department of Industrial Policy and Promotion (DIPP) upto May 2011.

Indian pharmaceutical market is predicted to grow to US$ 55 billion by 2020 from US$ 12.6 billion in 2009, as per a McKinsey report.

The Indian pharma industry is estimated to grow manifolds, on back of a high middle-class population base, improvements in medical infrastructure and the establishment of intellectual property rights.

The Indian pharmaceutical sector has registered an outstanding growth during the last few years and has become the hub of pharmaceutical companies owing to low cost manufacturing, large population, and high demand, as per a research report - Global Contract Manufacturing Market Analysis.

Generics

India tops the world in exporting generic medicines worth US$ 11 billion and currently, the Indian pharmaceutical industry is one of the world's largest and most developed, according to Mr Srikant Kumar Jena, Union Minister of State for Chemicals and Fertilisers.

The Indian generic drug market is expected to grow at a CAGR of around 17 per cent between 2010-11 and 2012-13.

Generics will continue to dominate the market while patent-protected products are likely to constitute 10 per cent of the pie till 2015, according to McKinsey report ‘India Pharma 2015 - Unlocking the potential of Indian Pharmaceuticals market’. Moreover, as per a press release by research firm RNCOS, the report titled ‘Booming Generics Drug Market in India' projects the Indian generic drug market to grow at a CAGR of around 17 per cent between 2010-11 and 2012-13.
 
.
The Indian pharmaceutical industry, now a $17 billion(over Rs 68,000 crore) Industry, has shown tremendous progress in terms of infrastructure development, technology base creation and a wide range of products. It has established its presence and determination to flourish in the changing environment. The industry now produces bulk drugs belonging to all major therapeutic groups requiring complicated manufacturing technologies. Formulations in various dosage forms are being produced in GMP compliant facilities. Strong scientific and technical manpower and pioneering work done in process development have made these possible. The country now ranks 4th worldwide accounting for 8% of world’s production by volume and 1.5% by value. It ranks 17th in terms of export value of bulk actives and dosage forms. Indian exports are destined to more than 200 countries around the globe including highly regulated markets of US, Europe, Japan and Australia.

The country is also showing excellent performance on the Pharma export front. The figures of exports under this category during the current decade have been:




About Us
 
.
Every country take protectionist measure to save its local industry and so will pakistan.Why you indians are breaking you head.Why dont you open your retail sectors to walmart and inssurance sector to foreign firms.you too have protectionist measure on many of your sectors then why complain if pakistan use such measure.

It doesnt matter to us if your pharma industry is billion dollar or trillion dollar. pakistan will use protectionist measure and only buy medicine when needed but wont open sector for indian companies.period.
 
.
Every country take protectionist measure to save its local industry and so will pakistan.Why you indians are breaking you head.Why dont you open your retail sectors to walmart and inssurance sector to foreign firms.you too have protectionist measure on many of your sectors then why complain if pakistan use such measure.

It doesnt matter to us if your pharma industry is billion dollar or trillion dollar. pakistan will use protectionist measure and only buy medicine when needed but wont open sector for indian companies.period.

wall mart already entered Into India.recently opened a small city called Vijayawada. second store going to open in Guntur just 38 km away from Vijayawada. Total 4 stores in Andhra pradesh Guntur,Vijayawada, Vizag, Hyderabad.

Bharti Walmart opened in Vijayawada
 
.
If it's true, then who was responsible to add this in the list of imports? Did they not apply their minds to the issue before doing so? Who's fault is it? It's no point bellyaching after the deed is done! Period!
 
.
I think a solution to pakistan companies and its poor people asking access to cheap medicine is : The GOP should ask pakistan's companies to import indian medicines and distribute it through their retails and their brand name....
It will help in reduction of cost of medicine, help pakistan companies survive the competition, and also help indian companies earn royalty on sale of drugs to pakistan companies...
 
.
every indian company wishing to do business in pakistan must be charged with 10% kashmir freedom movement tax and 10% L-e-T tax.That will take care of finances for freedom fighters' fighting for kashmir freedom

cr@psss!!!!
ya now we are hearing kashmiris in *** and baloch's have started agitating against pakistan's contrrol....
Perhaps we should put 10% baloch freedom fighter tax on pakistan goods :P

Bottomline internal :Stop trolling
 
.

Pakistan Defence Latest Posts

Back
Top Bottom